Frontline Asciminib Combination in Chronic Phase Chronic Myeloid Leukemia Patients. The FASCINATION Trial

被引：0
|
作者：
Ernst, T. [1 ]
Le Coutre, P. [2 ]
Crysandt, M. [3 ]
Bruemmendorf, T. H. [3 ]
Franke, G. -N. [4 ]
Illmer, T. [5 ]
Burchert, A. [6 ]
Lang, F. [7 ]
Saussele, S. [8 ]
Teichmann, L. [9 ]
Radsak, M. P. [10 ]
Krause, S. W. [11 ]
Rinke, J. [1 ]
Fabisch, C. [1 ]
Lang, T. [12 ]
Pfirrmann, M. [12 ]
Hochhaus, A. [1 ]
机构：
[1] Univ Klinikum Jena, Hamatol Onkol, Jena, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Univ Klinikum Aachen, Aachen, Germany
[4] Univ Klinikum Leipzig, Leipzig, Germany
[5] GOKOS GmbH, Dresden, Germany
[6] Univ Klinikum Marburg, Marburg, Germany
[7] Univ Klinikum Frankfurt, Frankfurt, Germany
[8] Univ Med Mannheim, Mannheim, Germany
[9] Univ Klinikum Bonn, Bonn, Germany
[10] Univ Med Mainz, Mainz, Germany
[11] Univ Klinikum Erlangen, Erlangen, Germany
[12] Ludwig Maximilians Univ Munchen, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V489
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] Asciminib in the treatment of chronic myeloid leukemia in chronic phase
    Costa, Alessandro
    Scalzulli, Emilia
    Bisegna, Maria Laura
    Breccia, Massimo
    FUTURE ONCOLOGY, 2025, 21 (07) : 815 - 831
  • [2] Asciminib in chronic myeloid leukemia
    Assanto, Giovanni Manfredi
    Scalzulli, Emilia
    Breccia, Massimo
    DRUGS OF TODAY, 2022, 58 (10) : 479 - 489
  • [3] Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study
    Yeung, David T.
    Shanmuganathan, Naranie
    Reynolds, John
    Branford, Susan
    Walia, Mannu
    Yong, Agnes S. M.
    Shortt, Jake
    Chee, Lynette
    Viiala, Nicholas
    Cunningham, Ilona
    Ross, David M.
    D'Souza, Alwyn
    Wright, Matthew
    Harrup, Rosemary
    Forsyth, Cecily
    Filshie, Robin
    Lane, Steven
    Browett, Peter
    Grove, Carolyn
    Grigg, Andrew P.
    Hughes, Timothy P.
    BLOOD, 2024, 144 (19) : 1993 - 2001
  • [4] Asciminib for the Treatment of Patients With Chronic Myeloid Leukemia
    Cortes, Jorge
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (04) : 207 - 208
  • [5] DASATINIB FRONTLINE IN ELDERLY PATIENTS WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA
    Stagno, F.
    Breccia, M.
    Annunziata, M.
    Trawinska, M.
    Iurlo, A.
    Sgherza, N.
    Fava, C.
    Gozzini, A.
    Luciano, L.
    Bonifacio, M.
    Sora, F.
    Crescenzi, S. Leonetti
    Bocchia, M.
    Crugnola, M.
    Gugliotta, G.
    Capodanno, I.
    Galimberti, S.
    Feo, C.
    Porrini, R.
    Pregno, P.
    Tiribelli, M.
    Rizzo, M.
    Mauro, E.
    Antolino, A.
    Rossi, A. Russo
    Guarini, A.
    Abruzzese, E.
    Vigneri, P.
    Latagliata, R.
    HAEMATOLOGICA, 2017, 102 : 90 - 91
  • [6] Asciminib in Relapsed Chronic Myeloid Leukemia
    Sahin, Ilyas
    Reagan, John L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14): : 1378 - 1379
  • [7] Phase II Clinical Trial Results of Dasatinib for Frontline Therapy in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
    Pemmaraju, Naveen
    Kantarjian, Hagop M.
    O'Brien, Susan
    Borthakur, Gautam
    Ravandi, Farhad
    Verstovsek, Srdan
    Daver, Naval G.
    Garcia-Manero, Guillermo
    DiNardo, Courtney D.
    Skinner, Jeff
    Konopleva, Marina
    Pierce, Sherry
    Jabbour, Elias
    Cortes, Jorge E.
    BLOOD, 2014, 124 (21)
  • [8] ASCIMINIB, A NEW THERAPEUTIC OPTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Garcia-Gutierrez, V
    Boque Genovard, C.
    Velez Tenza, P.
    Giraldo, P.
    Ramirez, M. J.
    Alonso-Dominguez, J. M.
    Jimenez Velasco, A.
    de Abia, Luna A.
    Hernadez-Boluda, J. C.
    HAEMATOLOGICA, 2019, 104 : 302 - 303
  • [9] Platelet function in patients with chronic myeloid leukemia treated with asciminib
    Nesr, George
    Laffan, Mike
    Claudiani, Simone
    Innes, Andrew
    Apperley, Jane
    Milojkovic, Dragana
    LEUKEMIA & LYMPHOMA, 2020, 61 (12) : 3021 - 3023
  • [10] Combination of Asciminib plus Nilotinib or Asciminib plus Dasatinib in Previously Treated Chronic Myeloid Leukemia (CML) Patients: Phase 1 Study Results
    DeAngelo, Daniel J.
    Mauro, Michael J.
    Kim, Dong-Wook
    Cortes, Jorge
    Rea, Delphine
    Hughes, Timothy P.
    Minami, Hironobu
    Breccia, Massimo
    Talpaz, Moshe
    Hochhaus, Andreas
    Goh, Yeow Tee
    Le Coutre, Philipp D.
    Sondhi, Manu
    Mishra, Kaushal
    Hourcade-Potelleret, Florence
    Vanasse, Gary
    Aimone, Paola
    Lang, Fabian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S290 - S291
12345